NCT05275504 2022-06-09
Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
TransThera Sciences (Nanjing), Inc.
Phase 1 Unknown
TransThera Sciences (Nanjing), Inc.
First Affiliated Hospital Xi'an Jiaotong University